In April, 2012, scientists from Europe, the US and Africa met at the “Le Lagon” Hotel in Dakar, Senegal, to discuss a future research agenda for monitoring the impact of meningococcal vaccines in Africa. The meeting was jointly organised by the London School of Hygiene & Tropical Medicine and the Centres for Disease Control and Prevention (CDC), Atlanta. The delegates attending the meeting in Dakar came from 12 different countries around the world and were scientists with expertise in public health, microbiology, immunology, epidemiology, health economics and clinical infectious diseases. Key representatives from funding agencies also attended.
Over two days, delegates discussed priorities for meningococcal research in Africa including evaluating the impact of MenAfriVac™ and other meningococcal vaccines in the meningitis belt. The first day included talks by leading scientists in the area of meningococcal research. On the second day, two working groups considered the epidemiological and laboratory research agendas respectively. At the last session, research priorities identified by each group were reported and refined. The importance of surveillance was underscored by both working groups. Minutes of the meeting were made available to all participants and a manuscript setting out the key research recommendations is in preparation for publication in a peer-reviewed journal. Funding for the meeting was
provided by The Bill & Melinda Gates Foundation.
Please see here links to the presentations and meeting papers